iTeos Therapeutics, Inc. (ITOS)
USD 7.26
(-5.59%)
USD 7.26
(-5.59%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -103.75 Million | -111.19 Million | 513.14 Million | -25.17 Million | -23.14 Million | -19.09 Million |
| Net Income | -112.64 Million | 96.65 Million | 214.52 Million | -38.03 Million | -22.45 Million | -18.05 Million |
| Depreciation & Amortization | 898 Thousand | 803 Thousand | 603 Thousand | 535 Thousand | 611 Thousand | 505 Thousand |
| Deferred income taxes | -3.03 Million | - | - | -1.26 Million | -1.01 Million | 130 Thousand |
| Stock-based compensation | 27.02 Million | 21.56 Million | 13.79 Million | 4.29 Million | 809 Thousand | 112 Thousand |
| Change in working capital | -8.79 Million | -228.49 Million | 284.21 Million | 9.33 Million | -1.08 Million | -1.85 Million |
| Other non-cash items | -7.19 Million | -1.71 Million | 12 Thousand | -35 Thousand | -10 Thousand | 69 Thousand |
| Investing Cash Flow | 72.65 Million | -446.06 Million | -1.24 Million | -377 Thousand | -926 Thousand | -299 Thousand |
| Investments in PPE | -2.96 Million | -938 Thousand | -1.18 Million | -356 Thousand | -721 Thousand | -226 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | -290.54 Million | -445 Million | - | - | - | - |
| Sales/Maturities of investments | 366.26 Million | - | - | - | - | - |
| Other Investing Activities | -99 Thousand | -120 Thousand | -61 Thousand | -21 Thousand | -205 Thousand | -73 Thousand |
| Financing Cash Flow | 1.11 Million | 1.98 Million | 3.65 Million | 340.33 Million | 22.53 Million | 23.5 Million |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | -332 Thousand | - | -226 Thousand |
| Common Stock Issuance | 1.11 Million | 925 Thousand | 2.94 Million | 213.66 Million | 22.47 Million | 23.33 Million |
| Other Financing Activities | 1.11 Million | 1.05 Million | 716 Thousand | 127.01 Million | 65 Thousand | 23.73 Million |
| Accounts receivables | -2.38 Million | 3.98 Million | -3.34 Million | 5.03 Million | -4.85 Million | 1.08 Million |
| Accounts payables | 3.03 Million | 2.76 Million | 2.28 Million | 1.67 Million | -155 Thousand | -133 Thousand |
| Inventory | 2.38 Million | -3.98 Million | 3.34 Million | -5.03 Million | 4.85 Million | -1.27 Million |
| Other working capital | -11.83 Million | -231.25 Million | 281.93 Million | 7.65 Million | -927 Thousand | -1.53 Million |
| Cash at beginning of period | 285.03 Million | 848.83 Million | 336.45 Million | 19.99 Million | 22.05 Million | 18.81 Million |
| Cash at end of period | 251.45 Million | 285.03 Million | 848.83 Million | 336.45 Million | 19.99 Million | 22.05 Million |
| Capital Expenditure | -2.96 Million | -938 Thousand | -1.18 Million | -356 Thousand | -721 Thousand | -226 Thousand |
| Effect of forex changes on cash | -3.6 Million | -8.52 Million | -3.17 Million | 1.67 Million | -532 Thousand | -875 Thousand |
| Net cash flow / Change in cash | -33.58 Million | -563.79 Million | 512.38 Million | 316.46 Million | -2.06 Million | 3.23 Million |
| Free Cash Flow | -106.72 Million | -112.13 Million | 511.95 Million | -25.53 Million | -23.86 Million | -19.32 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -7.12 Million | -38.21 Million | -112.64 Million | -30.55 Million | -32.24 Million | -34.3 Million |
| Depreciation & Amortization | 309 Thousand | 303 Thousand | 898 Thousand | 227 Thousand | 224 Thousand | 225 Thousand |
| Deferred income taxes | - | - | -3.03 Million | - | - | - |
| Stock-based compensation | 8.06 Million | 7.26 Million | 27.02 Million | 7.19 Million | 7.05 Million | 6.96 Million |
| Change in working capital | -32.38 Million | 990 Thousand | -8.79 Million | 11.55 Million | -6.26 Million | 101 Thousand |
| Other non-cash items | 37.9 Million | 10.29 Million | -7.19 Million | -2.18 Million | -2.66 Million | -2.53 Million |
| Investing Cash Flow | 16.32 Million | -69.6 Million | 72.65 Million | 61.55 Million | 22.69 Million | 20.1 Million |
| Investments in PPE | -442 Thousand | -945 Thousand | -2.96 Million | -1.39 Million | -751 Thousand | -700 Thousand |
| Acquisitions | - | - | - | -10.77 Million | - | -20.8 Million |
| Investment purchases | -89.22 Million | -155.85 Million | -290.54 Million | -97.03 Million | -54.47 Million | -86.46 Million |
| Sales/Maturities of investments | 105.98 Million | 87.19 Million | 366.26 Million | 159.99 Million | 78 Million | 107.26 Million |
| Other Investing Activities | - | -6.06 Million | -99 Thousand | -16 Thousand | -83 Thousand | 20.8 Million |
| Financing Cash Flow | 122.37 Million | 22 Thousand | 1.11 Million | 307 Thousand | 10 Thousand | 218 Thousand |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 122.37 Million | 22 Thousand | 1.11 Million | 307 Thousand | 10 Thousand | 218 Thousand |
| Other Financing Activities | 122.37 Million | 22 Thousand | 1.11 Million | 307 Thousand | 10 Thousand | 218 Thousand |
| Accounts receivables | -37.34 Million | 384 Thousand | -2.38 Million | -2.26 Million | 26 Thousand | -699 Thousand |
| Accounts payables | 5.33 Million | -5.55 Million | 3.03 Million | 7.61 Million | -2.06 Million | -408 Thousand |
| Inventory | - | - | 2.38 Million | 2.26 Million | -26 Thousand | 699 Thousand |
| Other working capital | -367 Thousand | 6.15 Million | -11.83 Million | 3.93 Million | -4.2 Million | 509 Thousand |
| Cash at beginning of period | 146.64 Million | 251.17 Million | 285.03 Million | 204.4 Million | 216.48 Million | 225.59 Million |
| Cash at end of period | 251.09 Million | 146.64 Million | 251.45 Million | 251.45 Million | 204.4 Million | 216.48 Million |
| Capital Expenditure | -442 Thousand | -945 Thousand | -2.96 Million | -1.39 Million | -751 Thousand | -700 Thousand |
| Effect of forex changes on cash | -289 Thousand | -2.55 Million | -3.6 Million | -1.04 Million | -895 Thousand | 112 Thousand |
| Net cash flow / Change in cash | 104.45 Million | -104.52 Million | -33.58 Million | 47.05 Million | -12.08 Million | -9.11 Million |
| Free Cash Flow | -34.36 Million | -33.34 Million | -106.72 Million | -15.16 Million | -34.64 Million | -30.24 Million |
CRR-UN
FRLOF
SHL
3DA
AGY
UTRX